Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier
- Vol. 67 (4) , 994-1000
- https://doi.org/10.1016/s0003-4975(99)00062-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical evaluation of Duraflo® II heparin treated extracorporeal circulation circuits (2nd version) The European working group on heparin coated extracorporeal circulation circuitsEuropean Journal of Cardio-Thoracic Surgery, 1997
- Heparin-coated circuits and aprotinin prime for coronary artery bypass graftingThe Annals of Thoracic Surgery, 1996
- Beneficial effects of duraflo II heparin-coated circuits on postperfusion lung dysfunctionThe Annals of Thoracic Surgery, 1996
- Effective Use of Heparin-Bonded Circuits and Lower Anticoagulation for Coronary Artery Bypass Grafting in Jehovah's WitnessesJournal of Cardiac Surgery, 1996
- High and low heparin dose with heparin-coated cardiopulmonary bypass: Activation of complement and granulocytesThe Annals of Thoracic Surgery, 1995
- Heparin-coated cardiopulmonary bypass circuits: Hemostatic alterations and postoperative blood lossThe Annals of Thoracic Surgery, 1994
- Complement activation during cardiopulmonary bypass: Effects of immobilized heparinThe Annals of Thoracic Surgery, 1994
- Heparin-coated bypass circuits reduce pulmonary injuryThe Annals of Thoracic Surgery, 1993
- Formation of C5a during cardiopulmonary bypass: Inhibition by precoating with heparinThe Annals of Thoracic Surgery, 1991
- Heparin-coating of extracorporea circuits reduces thrombin formation in patients undergoing cardiopulmonary bypassPerfusion, 1991